Severe systemic thrombosis in a young COVID-19 patient with a rare homozygous prothrombin G20210A mutation
Infez Med
; 29(2):259-262, 2021.
Article
in English
| PubMed | ID: covidwho-1248645
ABSTRACT
COVID-19 patients may experience a hypercoagulable condition, leading to thrombotic events. We describe a patient with COVID-19, carrying a rare homozygous mutation of the prothrombin gene, who developed a severe systemic vein thrombosis. In COVID-19 patients with hypercoagulability disorders the most common inherited and acquired risk factors should be investigated.
Search on Google
Collection:
Databases of international organizations
Database:
PubMed
Language:
English
Journal:
Infez Med
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS